SCHEMBL625128

SCHEMBL625128

CC(C)(C)OC(=O)N1CCC(Nc2nn3cc(-c4cnc(N)c(C(F)(F)F)c4)nc3s2)CC1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 1/20 0.46
CDK2 P24941 1/20 0.46
SYK P43405 1/20 0.45
PIK3CA P42336 2/20 0.41
RIPK1 Q13546 2/20 0.41
MAP3K12 Q12852 5/20 0.41
IDH1 O75874 1/20 0.41
IDH2 P48735 1/20 0.41
MAP4K1 Q92918 1/20 0.40
CCNT1 O60563 1/20 0.40
DYRK1A Q13627 1/20 0.39
GPR119 Q8TDV5 1/20 0.39
JAK1 P23458 1/20 0.38
SFRP1 Q8N474 1/20 0.38
HDAC4 P56524 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625456 0.91 MAP3K12 (0.41) CCNA2CDK2SYKPIK3CARIPK1
SCHEMBL625408 0.90 MAP4K1 (0.39) CCNA2CDK2SYKPIK3CAMAP3K12
SCHEMBL624428 0.89 MAP3K12 (0.47) SYKPIK3CAMAP3K12
SCHEMBL624985 0.88 KDM4E (0.40) SYKPIK3CAMAP3K12MAP4K1GPR119
SCHEMBL626892 0.88 PIK3CA (0.42) PIK3CAMAP3K12MAP4K1
SCHEMBL625127 0.85 PIK3CA (0.48) CCNA2CDK2SYKPIK3CARIPK1
SCHEMBL624922 0.85 PIK3CA (0.42) PIK3CARIPK1MAP3K12MAP4K1GPR119
SCHEMBL625861 0.85 GPR119 (0.46) CCNA2CDK2SYKIDH1IDH2
SCHEMBL625422 0.84 PIK3CA (0.42) PIK3CAMAP3K12
SCHEMBL626207 0.84 MAP3K12 (0.46) CDK2PIK3CAMAP3K12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed